Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Inés Llinares-BurguetSplicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas-Universidad de Valladolid (CSIC-UVa), 47003 Valladolid, Spain.ORCID 0000-0002-7838-0838
Lara Sanoguera-MirallesSplicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas-Universidad de Valladolid (CSIC-UVa), 47003 Valladolid, Spain.ORCID 0000-0002-5548-7114
Elena Bueno-MartínezSplicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas-Universidad de Valladolid (CSIC-UVa), 47003 Valladolid, Spain.ORCID 0000-0003-4888-2885
Ada Esteban-SanchezMolecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain.ORCID 0000-0002-1850-590X
Daniel Romano-MedinaSplicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas-Universidad de Valladolid (CSIC-UVa), 47003 Valladolid, Spain.
Lobna Ramadane-MorchadiMolecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain.ORCID 0009-0001-8199-3483
Alicia García-ÁlvarezSplicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas-Universidad de Valladolid (CSIC-UVa), 47003 Valladolid, Spain.
Pedro Pérez-SeguraMolecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain.
Doug F EastonCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
Peter DevileeDepartment of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-8023-2009
Maaike P G VreeswijkDepartment of Human Genetics, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0003-4068-9271
Miguel de la HoyaMolecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), 28040 Madrid, Spain.ORCID 0000-0002-8113-1410
Eladio A Velasco-SampedroSplicing and Genetic Susceptibility to Cancer, Unidad de Excelencia Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas-Universidad de Valladolid (CSIC-UVa), 47003 Valladolid, Spain.ORCID 0000-0002-9682-5589
Funding
Consejería de Educación de la Junta de Castilla y León Programa Estratégico, Escalera de Excelencia Instituto de Biomedicina y Genética Molecular (IBGM) de ValladolidEuropean Commission 634935Instituto de Salud Carlos III PI23/00047Instituto de Salud Carlos III PI24/00267
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Experimental Mis-Splicing Assessment and ACMG/AMP-Guided Classification of 47 · full record | OpenQuestion